ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,032Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 336

$665K Total Retail Price of All Prescriptions

Rank: 101 out of 336

674 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 674 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 674 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 11,984 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 522 479 1 1
OMEPRAZOLE 460 407 2 3
PRAVASTATIN SODIUM 403 375 3 10
LISINOPRIL 401 365 4 6
LEVOTHYROXINE SODIUM 391 366 5 7
HYDROCHLOROTHIAZIDE 351 338 6 12
HYDROCODONE-ACETAMINOPHEN 336 302 S3 7 2
METOPROLOL SUCCINATE 284 280 8 15
WARFARIN SODIUM 267 258 9 17
ZOLPIDEM TARTRATE 230 201 10 18
FUROSEMIDE 219 196 11 4
POTASSIUM CHLORIDE 216 200 12 9
SERTRALINE HCL 215 207 13 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 205 199 14 23
MELOXICAM 185 182 15 19
GABAPENTIN 169 141 16 11
SIMVASTATIN 164 161 17 5
TRIAMTERENE-HCTZ 153 136 18 35
SYNTHROID 152 149 19 43
LOSARTAN POTASSIUM 140 129 20 22
ATORVASTATIN CALCIUM 139 130 21 14
CARVEDILOL 132 121 22 13
GLIPIZIDE ER 131 116 23 91
ATENOLOL 128 121 24 26
DIOVAN 126 113 25 31
DIOVAN HCT 124 121 26 41
CRESTOR 124 113 26 25
NAMENDA 118 118 28 39
ESCITALOPRAM OXALATE 118 110 28 69
ALLOPURINOL 115 102 30 30
LOVASTATIN 112 108 31 34
METFORMIN HCL ER 111 107 32 61
CLOPIDOGREL 111 104 32 28
FLUTICASONE PROPIONATE 111 107 32 49
CYMBALTA 110 87 35 52
AZITHROMYCIN 110 96 35 58
METFORMIN HCL 109 97 37 8
BYSTOLIC 106 95 38 79
METOPROLOL TARTRATE 105 103 39 16
CITALOPRAM HBR 104 93 40 21
TRAMADOL HCL 103 103 41 20
LOSARTAN-HYDROCHLOROTHIAZIDE 87 87 42 45
TAMSULOSIN HCL 87 75 42 38
BENAZEPRIL HCL 80 80 44 59
GLYBURIDE-METFORMIN HCL 77 74 R 45 78
DONEPEZIL HCL 76 76 46 27
KLOR-CON M20 74 69 47 51
TRAZODONE HCL 73 68 48 46
BENICAR 73 62 48 112
AMITRIPTYLINE HCL 68 68 R 50 57
NEXIUM 68 59 50 24
SPIRONOLACTONE 66 61 52 42
GLIPIZIDE 65 60 53 71
VYTORIN 65 63 53 122
CIPROFLOXACIN HCL 62 61 55 55
CELEBREX 61 51 56 105
NIASPAN 59 59 57 139
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 54 58 89
LEXAPRO 57 57 59 197
ESTRADIOL 57 53 R 59 129
PLAVIX 56 54 61 37
EVISTA 54 54 62 106
RAMIPRIL 53 53 63 84
RANITIDINE HCL 53 42 63 36
PROPRANOLOL HCL 51 51 65 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.